Physician profile
Timothy Stapleton
NPI 1609836402
$5,678.33
in general payments reported to CMS, 2019-2025
13 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,904 · 2020: $123 · 2021: $1,507 · 2022: $62.37 · 2023: $26.33 · 2024: $167 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,062 · Food and Beverage: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,062.09 |
| Food and Beverage | $1,019.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,871.72 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,714.03 | 2021-2025 | Persona, Tapestry |
| Restor3d, INC. | $1,509.40 | 2025 | |
| Miach Orthopaedics, INC. | $211.95 | 2025 | |
| Smith+Nephew, INC. | $141.55 | 2019-2025 | |
| Pacira Therapeutics, INC. | $44.97 | 2019-2021 | |
| Depuy Synthes Sales INC. | $42.91 | 2020 | |
| Innovation Technologies INC | $36.61 | 2022 | |
| Radius Health, INC. | $27.64 | 2021 | |
| Heron Therapeutics, INC. | $26.33 | 2023 | Zynrelef |
| Illuminoss Medical, INC. | $24.96 | 2024 | |
| Stryker Corporation | $21.36 | 2020 | |
| Orthofix Medical, INC. | $4.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.